Literature DB >> 591065

Effect of alveolar macrophages on Toxoplasma gondii.

F W Ryning, J S Remington.   

Abstract

As pulmonary involvement can occur in disseminated toxoplasmosis in immunosuppressed patients, studies were initiated to define local mechanisms of resistance of the lung to Toxoplasma gondii. Alveolar macrophages were obtained from normal mice and mice chronically infected with T. gondii by bronchopulmonary lavage and cultured in vitro. Although normal alveolar macrophages were difficult to infect with Toxoplasma, they supported intracellular multiplication of this organism. When exposed to Toxoplasma that had been pretreated with heat-inactivated serum containing specific antibody, the number of intracellular organisms increased remarkably, and the macrophages destroyed the coated parasites. After development of chronic infections with Toxoplasma, there was a transient period during which a striking increase in numbers of alveolar macrophages was observed in lavage specimens. These macrophages differed from those of normal alveolar macrophages. There was a greater percentage of large cells, a greater tendency to spread on glass, and an increased number of intracellular Toxoplasma, and the cells were activated to kill or inhibit multiplication of the parasite. During the period when activated macrophages were demonstrable in bronchopulmonary washings, histological changes in the lungs revealed a marked mononuclear cell infiltrate. These studies support a role for the activated alveolar macrophage as an effector in resistance of the lung to infection with Toxoplasma.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 591065      PMCID: PMC421298          DOI: 10.1128/iai.18.3.746-753.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  SIMPLIFIED MYELOPEROXIDASE STAIN USING BENZIDINE DIHYDROCHLORIDE.

Authors:  L S KAPLOW
Journal:  Blood       Date:  1965-08       Impact factor: 22.113

2.  Ocular toxoplasmosis; pathogenesis, diagnosis and treatment.

Authors:  J K FRENKEL; L JACOBS
Journal:  AMA Arch Ophthalmol       Date:  1958-02

3.  Intracellular multiplication of Toxoplasma gondi in adult mammalian macrophages cultivated in vitro.

Authors:  W A VISCHER; E SUTER
Journal:  Proc Soc Exp Biol Med       Date:  1954-07

4.  Toxoplasmosis complicating malignancy. Experience at the National Cancer Institute.

Authors:  W M Vietzke; A H Gelderman; P M Grimley; M P Valsamis
Journal:  Cancer       Date:  1968-05       Impact factor: 6.860

5.  Adoptive immunity to intracellular infection.

Authors:  J K Frenkel
Journal:  J Immunol       Date:  1967-06       Impact factor: 5.422

6.  Role for the macrophage in acquired immunity to phylogenetically unrelated intracellular organisms.

Authors:  J Ruskin; J S Rengton
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

7.  Disseminated toxoplasmosis in the compromised host. A report of five cases.

Authors:  T H Gleason; W B Hamlin
Journal:  Arch Intern Med       Date:  1974-12

8.  Specific antibody-dependent killing of Toxoplasma gondii by normal macrophages.

Authors:  S E Anderson; S C Bautista; J S Remington
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

9.  Staining Toxoplasma gondii with fluorescein-labelled antibody. I. The reaction in smears of peritoneal exudate.

Authors:  M GOLDMAN
Journal:  J Exp Med       Date:  1957-06-01       Impact factor: 14.307

10.  Effect of normal and activated human macrophages on Toxoplasma gondii.

Authors:  S E Anderson; J S Remington
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

View more
  8 in total

1.  Group B streptococcal type Ia sepsis in mice after intranasal inoculation and the effect of infection on lungs.

Authors:  D E Wennerstrom
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

2.  Kinetics of phagocytosis of Staphylococcus aureus by alveolar and peritoneal macrophages.

Authors:  E L Pesanti
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

3.  Comparison of cytotoxic and microbicidal function of bronchoalveolar and peritoneal macrophages.

Authors:  F W Ryning; J L Krahenbuhl; J S Remington
Journal:  Immunology       Date:  1981-04       Impact factor: 7.397

4.  Nonoxidative microbicidal activity in normal human alveolar and peritoneal macrophages.

Authors:  J R Catterall; C M Black; J P Leventhal; N W Rizk; J S Wachtel; J S Remington
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

5.  Schistosoma mansoni larvicidal activity of murine bronchoalveolar lavage cells.

Authors:  F A Lewis; C A White-Ziegler; J E Ball; G M Niemann
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

6.  Adoptive transfer of protection against Trypanosoma cruzi with lymphocytes and macrophages.

Authors:  D E Burgess; W L Hanson
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

7.  Antibody in host defense against mouse pneumonitis agent (murine Chlamydia trachomatis).

Authors:  D M Williams; J Schachter; M H Weiner; B Grubbs
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

8.  Oxygen-independent killing by alveolar macrophages.

Authors:  J R Catterall; S D Sharma; J S Remington
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.